TD SYNNEX (NYSE: SNX) insider files to sell 5,853 shares under Rule 144

Rhea-AI Filing Summary

TD SYNNEX (SNX) has a notice of proposed insider sale under Rule 144 for 5,853 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $901,420.53. These shares were acquired as restricted stock units from the issuer on 01/24/2023, with the same date listed as the payment date.

The filing also lists recent sales of TD SYNNEX common stock over the past three months for the same account group: 3,000 shares sold on 11/04/2025 for gross proceeds of $451,697.45, 17,500 shares sold on 10/09/2025 for $2,738,783.60, and 3,000 shares sold on 10/06/2025 for $477,258.30. The issuer reports 81,437,855 shares of common stock outstanding.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5853	901420.53	81437855	12/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/24/2023	Restricted Stock Units	Issuer			5853	01/24/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for POLK FAMILY TRUST U/T/A DTD 04/25/2007 44201 Nobel Drive Fremont CA 94538	Common	11/04/2025	3000	451697.45
Dennis Polk 44201 Nobel Drive Fremont CA 94538	Common	10/09/2025	17500	2738783.60
10b5-1 Sales for POLK FAMILY TRUST U/T/A DTD 04/25/2007 44201 Nobel Drive Fremont CA 94538	Common	10/06/2025	3000	477258.30

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider transaction is disclosed for TD SYNNEX (SNX) in this notice?

The notice discloses a proposed sale under Rule 144 of 5,853 shares of TD SYNNEX common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $901,420.53.

How and when were the TD SYNNEX (SNX) shares being sold acquired?

The 5,853 shares being sold were acquired as restricted stock units from the issuer. The acquisition date is listed as 01/24/2023, which is also the stated date of payment, with the nature of payment recorded as N/A.

What recent TD SYNNEX (SNX) stock sales are reported for the same account?

Over the past three months, the filing reports TD SYNNEX common stock sales including 3,000 shares on 11/04/2025 for $451,697.45, 17,500 shares on 10/09/2025 for $2,738,783.60, and 3,000 shares on 10/06/2025 for $477,258.30.

What does the filing say about TD SYNNEX (SNX) shares outstanding?

The filing lists 81,437,855 shares of TD SYNNEX common stock outstanding in the class from which the 5,853 shares are proposed to be sold.

Which broker is handling the TD SYNNEX (SNX) Rule 144 sale?

The proposed Rule 144 sale of 5,853 TD SYNNEX common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What representation does the seller make about TD SYNNEX (SNX) information?

The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about TD SYNNEX’s current or prospective operations that has not been publicly disclosed.